HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
AssigneeCytlimic Inc.
InventorsTomoya Miyakawa, Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka
Life of this patent
Estimating the term…
Abstract
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.
Claims5
A method for inducing an immune response in a subject suffering from cancer, comprising a step of administrating to the subject a peptide consisting of the amino acid sequence of SEQ ID NO:
- 7.
A method for inducing an immune response in a subject suffering from cancer, comprising a step of administrating to the subject a pharmaceutical composition comprising a peptide consisting of the amino acid sequence of SEQ ID NO:
- 7 and a pharmaceutically acceptable formulation component.
Dependencies are inferred from the claim text.